Advocacy in Action
Current Calls to Action
Legislative advocacy is an important element of the Florida Breast Cancer Foundation’s mission. With approval from the Foundation Board of Directors, we add our voice to weigh in on issues and legislation considered at both the State and Federal level.
YOUR VOICE CAN MAKE A DIFFERENCE. PLEASE HELP.
When it comes to a cancer diagnosis, early detection saves lives!
Florida ranks 3rd in the United States in the number of new breast cancer cases per year and 2nd in the number of deaths. An estimated 16,770 Floridian women will receive a breast cancer diagnosis and an estimated 2,880 are expected to die from the disease in 2016.
These are frightening statistics, but you can make a difference.
Mammography remains the single most effective method for early detection. It can identify cancer several years before physical symptoms develop! We know that when cancer is discovered early, treatment is more successful.
Background: The Mary Brogan Breast and Cervical Cancer Early Detection Program provides lifesaving cancer screenings for medically underserved women between the ages of 50 and 64 who otherwise would not have access to this type of care. Women diagnosed with cancer through the program are eligible to apply for a special Medicaid program that will cover the costs of their treatment. The program is funded from federal and state appropriations for that purpose.
The services provided through this program are vital and sadly, underfunded. Please contact your Senator and Representative and ask that they include $2.6 million in recurring funds for the Breast and Cervical Cancer Early Detection Program in this year’s state budget. It takes only one minute using our fast action form. Every additional dollar means more screenings for at-risk women!
2. "Right Medicine Right Time Act"
On the State Level
Senate Bill ?#?SB1084 —The "Right Medicine Right Time Act"; would require a managed care plan, an insurer, and a health maintenance organization to establish a process by which a prescribing physician may request an override of certain restrictions in certain circumstances; providing the circumstances under which an override must be granted; defining the term “fail-first protocol”; prohibiting a health maintenance organization from requiring that a health care provider use a clinical decision support system or a laboratory benefits management program in certain circumstances. Patients should receive the medication originally prescribed without having to first fail on a medication that their doctors already know will not work.
This bill has unanimous support of the Senate Banking and Health Policy committees and is now before the Senate Appropriations committee. Unfortunately the House did not hold any committee hearings on this bill. We will keep you posted if further action is needed.
What can YOU do? Share this post to help show your support! ?#?FailFirstHurts
Click here to learn more about "fail first"/"step therapy".http://bit.ly/1KV7FE
On the Federal Level
Background: Funding for breast cancer research (Breast Cancer Research Program – BCRP) is funded through the Department of Defense (DOD). In order to maintain funding for the DOD BCRP, money must be appropriated by Congress. The first step in this process is for the House Defense Appropriations Subcommittee to appropriate funding. Representatives King (R-NY), McGovern (D-MA), Costello (R-PA) and Hastings (D-FL) are circulating a Dear Colleague Letter, asking House Members to sign a letter to the Defense Appropriations Subcommittee leadership, supporting level funding for the DOD BCRP.
What can YOU do? It is very important to take action and contact your Representative to sign this letter! The deadline for signing is March 14th! This listing identifies the Representatives who signed last year’s letter and should be contacted and urged to sign again. The key targets from Florida are Rep. Corrine Brown (D-5),Rep. Alan Grayson (D-9), Rep. Kathy Castor (D-14), Rep. Alcee Hastings (D-20),* Rep. Ted Deutch, (D-21) Rep. Lois Frankel, (D-22) Rep. Debbie Wasserman Schultz (D-23), Rep. Frederica S. Wilson (D-24).
The action you are taking will let your Representatives know how important the DOD BCRP is to breast cancer research.
Together we WILL end breast cancer!
A large portion of breast cancer research is funded through the U.S. Department of Defense (DOD). In order to maintain funding for the Department of Defense (DOD) Breast Cancer Research Program (BCRP), each year, money must be appropriated by Congress. Each year, FBCF supports this continued level funding for breast cancer research and will ask for your help with contacting local representatives.
Thanks to individuals who contacted their representives to urge them to supported this action, the Fiscal Year 2015 (FY15) Defense Appropriations Act will provide $120 million to the Department of Defense Breast Cancer Research Program (BCRP) to support innovative, high-impact breast cancer research to accelerate progress toward ending breast cancer.
If you would like to be part of the FBCF Advocacy Committee and receive timely Action Alerts, please contact us at email@example.com for more information.